Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
They are present in the smooth endoplasmic reticulum (SER) of the liver
Today, Novo Nordisk estimates that just under 20 million people are treated with GLP-1 drugs.4 Given a well-stocked pipeline, a substantial global addressable population (the obese population alone is projected to exceed 1.2 billion by 20305), and in light of the very beneficial clinical profile of these drugs, it is plausible that over 100 million patients worldwide will be treated with GLP-1s in the near future
411,412,413 The promotion of SCFA-producing bacteria induced by dietary fibers observed in T2DM patients suggests the potential value of fiber supplementation in clinical practice
While Victoza may cause weight loss as a side effect, only Saxenda is specifically approved for weight loss (see Can liraglutide be used for weight loss?)
Consult your doctor for the appropriate dosage
Li F, Zhang L, Sun Q
